Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1107 posts found.

shutterstock_204190579

UK cervical cancer screening rates fall to 21-year low

November 28, 2018
Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma

A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …

News
nhs_sign

NHS to save £300 million by switching to Humira biosimilars

November 27, 2018
Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma

NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …

News
nhs_andrew_tatlow

NHS hospitals paying 167% more for drugs since 2010/11

November 23, 2018
Medical Communications Cost, NHS, UK, hospitals, pricing

Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …

News

Cancer Drugs Fund to offer MSD’s Keytruda for lung cancer

November 22, 2018
Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NICE, UK, keytruda, pharma

MSD’s Keytruda (pembrolizumab) will now be made available via the Cancer Drugs Fund for patients in England, as NICE announces …

News

MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund

November 19, 2018
Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …

News

Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund

November 15, 2018
Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma

NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …

News
eisa0001

Eisai’s Lenvima wins over NICE in liver cancer in just three months

November 9, 2018
Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma

Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …

News
nice_new_london_office_internal_2_8

NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis

November 9, 2018
Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma

Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …

News

NHS diabetes prescriptions top £1 billion a year

November 9, 2018
Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma

The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …

News
jazz_pharma

Jazz Pharma’s Vyxeos secures NICE recommendation in acute myeloid leukaemia

November 8, 2018
Sales and Marketing Cancer, NHS, NICE, UK, Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has revealed that NICE has chosen to recommend that its 44mg/100mg powder formulation of Vyxeos for concentrate for …

News
abbvie_0

AbbVie sue NHS over hepatitis C drug procurement

November 8, 2018
Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling

American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached …

News
450px-official_portrait_of_matt_hancock_crop_2

Health Secretary launches new prevention strategy for NHS

November 6, 2018
Manufacturing and Production Matt Hancock, NHS, health, prevention

British Health Secretary Matt Hancock has said that healthcare should focus on prevention, as he launched a long-term strategy intended …

News
shutterstock_92671375

Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths

October 31, 2018
Research and Development ITH Pharma, Metropolitan Police, NHS, pharma

An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …

News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018
Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …

News

Half of kidney cancer patients initially misdiagnosed

October 30, 2018
Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis

Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026